141 related articles for article (PubMed ID: 6678966)
21. [11C]Vinblastine syntheses and preliminary imaging in cancer patients.
Solbach C; Patt M; Reimold M; Blocher A; Dohmen BM; Bares R; Zeller KP; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):266s-276s. PubMed ID: 17718930
[TBL] [Abstract][Full Text] [Related]
22. Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.
Kiya K; Uozumi T; Ogasawara H; Sugiyama K; Hotta T; Mikami T; Kurisu K
Cancer Chemother Pharmacol; 1992; 29(5):339-42. PubMed ID: 1312906
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
24. Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide.
Stewart DJ; Grewaal D; Redmond MD; Mikhael NZ; Montpetit VA; Goel R; Green RM
Cancer Chemother Pharmacol; 1993; 32(5):368-72. PubMed ID: 8339387
[TBL] [Abstract][Full Text] [Related]
25. Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.
Stewart DJ; Richard MT; Hugenholtz H; Dennery J; Nundy D; Prior J; Montpetit V; Hopkins HS
J Neurooncol; 1984; 2(4):315-24. PubMed ID: 6530619
[TBL] [Abstract][Full Text] [Related]
26. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
27. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
Houghton JA; Williams LG; Torrance PM; Houghton PJ
Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery.
Vavra M; Ali MJ; Kang EW; Navalitloha Y; Ebert A; Allen CV; Groothuis DR
Neuro Oncol; 2004 Apr; 6(2):104-12. PubMed ID: 15134624
[TBL] [Abstract][Full Text] [Related]
29. [Brain metastasis of choriocarcinoma in males. Apropos of a case. Review of the literature].
Soussain C; Michel-Langlet P; Mahjoubi M; Terrier-Lacombe MJ; Droz JP
Bull Cancer; 1992; 79(8):751-7. PubMed ID: 1281698
[TBL] [Abstract][Full Text] [Related]
30. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
31. Platinum concentrations in human autopsy tumor samples.
Stewart DJ; Mikhael NZ; Nair RC; Kacew S; Montpetit V; Nanji A; Maroun JA; Howard K
Am J Clin Oncol; 1988 Apr; 11(2):152-8. PubMed ID: 3358362
[TBL] [Abstract][Full Text] [Related]
32. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
[TBL] [Abstract][Full Text] [Related]
33. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.
Lu K; Yap HY; Loo TL
Cancer Res; 1983 Mar; 43(3):1405-8. PubMed ID: 6825110
[TBL] [Abstract][Full Text] [Related]
35. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.
Greig NH; Soncrant TT; Shetty HU; Momma S; Smith QR; Rapoport SI
Cancer Chemother Pharmacol; 1990; 26(4):263-8. PubMed ID: 2369790
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics of 4-acetyl tritium vinblastine in two patients.
Owellen RJ; Hartke CA
Cancer Res; 1975 Apr; 35(4):975-80. PubMed ID: 1116154
[TBL] [Abstract][Full Text] [Related]
37. Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: a self-controlled, pilot study.
Fang L; Sun X; Song Y; Zhang Y; Li F; Xu Y; Ma S; Lin N
Cancer Chemother Pharmacol; 2015 Oct; 76(4):873-7. PubMed ID: 26310285
[TBL] [Abstract][Full Text] [Related]
38. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
39. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.
Cortés J; Dieras V; Ro J; Barriere J; Bachelot T; Hurvitz S; Le Rhun E; Espié M; Kim SB; Schneeweiss A; Sohn JH; Nabholtz JM; Kellokumpu-Lehtinen PL; Taguchi J; Piacentini F; Ciruelos E; Bono P; Ould-Kaci M; Roux F; Joensuu H
Lancet Oncol; 2015 Dec; 16(16):1700-10. PubMed ID: 26596672
[TBL] [Abstract][Full Text] [Related]
40. Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).
Stewart DJ; Zhengang G; Lu K; Savaraj N; Feun LG; Luna M; Benjamin RS; Keating MJ; Loo TL
Cancer Chemother Pharmacol; 1984; 12(2):116-9. PubMed ID: 6583026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
